VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
495
New
Increased
Reduced
Closed

Top Buys

1 +$2.11M
2 +$2.09M
3 +$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

1 +$2.13M
2 +$2.13M
3 +$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
301
IDEAYA Biosciences
IDYA
$2.59B
$267K 0.07%
8,014
+195
NUVL icon
302
Nuvalent
NUVL
$8.72B
$267K 0.07%
2,602
+64
MGTX icon
303
MeiraGTx Holdings
MGTX
$986M
$265K 0.07%
30,570
+746
ABCL icon
304
AbCellera Biologics
ABCL
$1.88B
$263K 0.07%
75,327
+1,839
NGNE icon
305
Neurogene
NGNE
$448M
$263K 0.07%
13,033
+317
ABUS icon
306
Arbutus Biopharma
ABUS
$901M
$261K 0.07%
57,895
+1,412
SEPN
307
Septerna Inc
SEPN
$1.36B
$258K 0.07%
10,719
+262
AVBP icon
308
ArriVent BioPharma
AVBP
$1.41B
$258K 0.07%
11,165
+271
DYN icon
309
Dyne Therapeutics
DYN
$3.2B
$257K 0.07%
14,150
+344
IMVT icon
310
Immunovant
IMVT
$6.84B
$256K 0.07%
10,320
+251
PRTA icon
311
Prothena Corp
PRTA
$533M
$256K 0.07%
26,320
+641
JBIO
312
Jade Biosciences
JBIO
$1.04B
$256K 0.07%
18,203
+444
SION
313
Sionna Therapeutics
SION
$1.93B
$256K 0.07%
6,374
+154
KYMR icon
314
Kymera Therapeutics
KYMR
$6.7B
$253K 0.07%
3,040
+74
COGT icon
315
Cogent Biosciences
COGT
$5.97B
$249K 0.07%
6,476
+159
JANX icon
316
Janux Therapeutics
JANX
$890M
$248K 0.07%
17,821
+433
BCIC
317
BCP Investment Corp
BCIC
$93.1M
$247K 0.07%
32,830
-475
VKTX icon
318
Viking Therapeutics
VKTX
$3.8B
$239K 0.07%
7,354
+180
BEAM icon
319
Beam Therapeutics
BEAM
$3.39B
$237K 0.07%
9,966
+242
NAMS icon
320
NewAmsterdam Pharma
NAMS
$3.94B
$234K 0.06%
7,319
+177
FDMT icon
321
4D Molecular Therapeutics
FDMT
$518M
$234K 0.06%
25,154
+613
PRME icon
322
Prime Medicine
PRME
$641M
$231K 0.06%
66,508
+1,622
INBX icon
323
Inhibrx
INBX
$1.53B
$230K 0.06%
3,425
+82
ARVN icon
324
Arvinas
ARVN
$579M
$230K 0.06%
21,676
+528
QURE icon
325
uniQure
QURE
$1.8B
$229K 0.06%
13,977
+341